Introduction: Clinical laboratories play an important role in the diagnosis and monitoring of chronic kidney disease (CKD). Our aim was to evaluate the performance of qualitative and semi-quantitative albumin-to-creatinine ratio (ACR) and protein-to-creatinine ratio (PCR) test strip results as screening tools for albuminuria in multiple representative patient cohorts.
Materials And Methods: ACR and PCR were evaluated in both cross-sectional (n = 940) and validation (n = 927) patient cohorts. Semi-quantitative urinary ACR and PCR were performed using a UC-3500 instrument (Sysmex, Kobe, Japan). The diagnostic performance of semi-quantitative ACR and PCR was determined using quantitative ACR and PCR as reference method.
Results: In the cross-sectional cohort, a sensitivity and specificity of 78.1% and 93.3%, respectively, were obtained for semi-quantitative ACR at a cut-off of 30 mg/g creatinine, with an overall agreement of > 90% between both methods. The sensitivity and specificity increased in the target population (validation cohort) to 89.9% and 92.1%, respectively. In contrast, the sensitivities of qualitative protein concentration (78.6%) and semi-quantitative PCR (69.8%) were lower.
Conclusion: The results confirm that urine test strip readouts are a valuable screening tool for CKD in low-risk individuals. ACR should be the preferred criterion for reflex testing when using a urine test strip for screening CKD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1186/s12882-025-04048-9 | DOI Listing |
BMC Nephrol
March 2025
Department of Laboratory Medicine, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Introduction: Clinical laboratories play an important role in the diagnosis and monitoring of chronic kidney disease (CKD). Our aim was to evaluate the performance of qualitative and semi-quantitative albumin-to-creatinine ratio (ACR) and protein-to-creatinine ratio (PCR) test strip results as screening tools for albuminuria in multiple representative patient cohorts.
Materials And Methods: ACR and PCR were evaluated in both cross-sectional (n = 940) and validation (n = 927) patient cohorts.
Int J Nephrol Renovasc Dis
February 2025
Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine Universitas Brawijaya / Dr. Saiful Anwar General Hospital, Malang, Indonesia.
Introduction And Purpose: Lupus nephritis (LN) is the main cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients, therefore the discovery of new biomarkers, which are reliable for the diagnosis of NL is necessary. Various studies have reported alteration of some miRNAs expression in LN, that considered as biomarkers and/or therapeutic targets in LN. MicroRNA-203 has been associated with the development of nephritis in SLE patients, playing an important role in the initiation and progression of the disease, but research on circulating miRNA-203 expression in LN in clinical practice is still very limited.
View Article and Find Full Text PDFWorld J Surg
February 2025
Department of Endocrine Surgery, King George's Medical University, Lucknow, India.
Background: Pathological complete response (PCR) is the surrogate marker of the outcome of a breast cancer patient. Breast cancer (BC) patients have variable responses to neoadjuvant chemotherapy (NACT). The effect of chemotherapy on mammographic density (MD) is unclear in the literature.
View Article and Find Full Text PDFBMC Oral Health
February 2025
Institute of Dentistry, Faculty of Medicine, Vilnius University, Vilnius, 01131, Lithuania.
Background: Dry mouth-related conditions adversely affect patients' well-being, as well as their oral and general health. There are indications that the quantitative and qualitative protein composition of saliva is disrupted in patients with xerostomia and Sjögren's syndrome. Salivary α-amylase levels positively correlate with the copy number (CN) of its coding gene, AMY1 (amylase alpha 1).
View Article and Find Full Text PDFFront Immunol
February 2025
Division of Thoracic Surgery, University Hospital, LMU Munich, Munich, Germany.
Introduction: Acute rejection is a significant risk factor for developing chronic lung allograft dysfunction. Current monitoring tools, transbronchial biopsies and HLA antibody determination, have limitations in detecting acute rejection. This study aims to explore the potential utility of donor-derived cell-free DNA (ddcfDNA) as a non-invasive biomarker for detecting acute rejection in lung transplant recipients (LTR).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!